'Tomudex' (raltitrexed) plus 5-fluorouracil: A promising option for the treatment of patients with metastatic colorectal cancer

被引：1
|
作者：
Schwartz, GK
Bertino, J
Kemeny, N
Saltz, L
Kelsen, DK
Tong, W
Barazzuol, J
Lowery, C
Smith, M
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Zeneca Pharmaceut, Wilmington, DE USA
[3] Zeneca Pharmaceut, Alderley Pk, England
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)80666-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
233
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [41] Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer
    Schwartz, GK
    Bertino, J
    Kemeny, N
    Saltz, L
    Kelsen, DK
    Tong, W
    Welch, M
    Endres, S
    Dimery, I
    ANTI-CANCER DRUGS, 2004, 15 (03) : 219 - 227
  • [42] 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - REPLY
    BUDD, GT
    BUKOWSKI, RM
    MCCRACKEN, JD
    MACDONALD, JS
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) : 1492 - 1493
  • [43] Capecitabine in the treatment of metastatic colorectal cancer refractory to 5-fluorouracil chemotherapy.
    Salek, T
    Mardiak, J
    Mego, M
    Hlavata, Z
    Obertova, J
    Sycova-Mila, Z
    Minarik, T
    Sufliarsky, J
    Bohunicky, L
    Thalmeinerova, Z
    Koza, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 293S - 293S
  • [44] Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil
    deBraud, F
    Munzone, E
    Nole, F
    De Pas, T
    Biffi, R
    Brienza, S
    Aapro, MS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (03): : 279 - 283
  • [45] Oxaliplatin plus 5-fluorouracil: Clinical experience in patients with advanced colorectal cancer
    Bleiberg, H
    de Gramont, A
    SEMINARS IN ONCOLOGY, 1998, 25 (02) : 32 - 39
  • [46] Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer
    Françoise Bressolle
    Jean M. Joulia
    Frédéric Pinguet
    Marc Ychou
    Cécile Astre
    Jacqueline Duffour
    Roberto Gomeni
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 295 - 302
  • [47] Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer
    Bressolle, F
    Joulia, JM
    Pinguet, F
    Ychou, M
    Astre, C
    Duffour, J
    Gomeni, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (04) : 295 - 302
  • [48] Phase I and pharmacokinetic study of Tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer
    Caponigro, F
    Avallone, A
    McLeod, H
    Cartenì, G
    De Vita, F
    Casaretti, R
    Morsman, J
    Blackie, R
    Budillon, A
    De Lucia, L
    Gravina, A
    Catalano, G
    Comella, P
    Comella, G
    CLINICAL CANCER RESEARCH, 1999, 5 (12) : 3948 - 3955
  • [49] Randomized trial comparing weekly bolus 5-fluorouracil plus leucovorin versus monthly 5-day 5-fluorouracil plus leucovorin in metastatic colorectal cancer
    Wang, WS
    Lin, JK
    Chiou, TJ
    Liu, JH
    Fan, FS
    Yen, CC
    Lin, TC
    Jiang, JK
    Yang, SH
    Chen, PM
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1599 - 1603
  • [50] CONTINUOUS-INFUSION OF 5-FLUOROURACIL IN METASTATIC COLORECTAL-CANCER PATIENTS
    DEGRAEFF, A
    VANDEWOUW, AJ
    VANDEVEN, PJG
    TJIA, PF
    WITTEVEEN, PO
    NEIJT, JP
    ZONNENBERG, BA
    VENDRIK, CPJ
    NORTIER, JWR
    BLIJHAM, GH
    CANCER JOURNAL - FRANCE, 1993, 6 (03): : 159 - 162
12345